Environmental obesogens:: Organotins and endocrine disruption via nuclear receptor signaling

被引:575
作者
Grun, Felix [1 ]
Blumberg, Bruce [1 ]
机构
[1] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA
关键词
D O I
10.1210/en.2005-1129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the last two decades, the incidence of obesity and associated metabolic syndrome diseases has risen dramatically, becoming a global health crisis. Increased caloric intake and decreased physical activity are believed to represent the root causes of this dramatic rise. However, recent findings highlight the possible involvement of environmental obesogens, xenobiotic chemicals that can disrupt the normal developmental and homeostatic controls over adipogenesis and energy balance. Environmental estrogens, i.e. chemicals with estrogenic potential, have been reported to perturb adipogenic mechanisms using in vitro model systems, but other classes of endocrine-disrupting chemicals are now coming under scrutiny as well. Organotins represent one class of widespread persistent organic pollutants with potent endocrine-disrupting properties in both invertebrates and vertebrates. New data identify tributyltin chloride and triphenyltin chloride as nanomolar agonist ligands for retinoid X receptor (RXR alpha, RXR beta, and RXR gamma) and peroxisome proliferator-activated receptor gamma, nuclear receptors that play pivotal roles in lipid homeostasis and adipogenesis. The environmental obesogen hypothesis predicts that inappropriate receptor activation by organotins will lead directly to adipocyte differentiation and a predisposition to obesity and/or will sensitize exposed individuals to obesity and related metabolic disorders under the influence of the typical high-calorie, high-fat Western diet. The linking of organotin exposure to adipocyte differentiation and obesity opens an important new area of research into potential environmental influences on human health and disease.
引用
收藏
页码:S50 / S55
页数:6
相关论文
共 66 条
[1]   Peroxisome proliferator-activated receptor γ:: the more the merrier? [J].
Argmann, CA ;
Cock, TA ;
Auwerx, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (02) :82-92
[2]   Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? [J].
Armitage, JA ;
Khan, IY ;
Taylor, PD ;
Nathanielsz, PW ;
Poston, L .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 561 (02) :355-377
[3]   Organotins disrupt the 11β-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids [J].
Atanasov, AG ;
Nashev, LG ;
Tam, S ;
Baker, ME ;
Odermatt, A .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2005, 113 (11) :1600-1606
[4]   PPARγ, the ultimate thrifty gene [J].
Auwerx, J .
DIABETOLOGIA, 1999, 42 (09) :1033-1049
[5]   Chemical toxins: A hypothesis to explain the global obesity epidemic [J].
Baillie-Hamilton, PF .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (02) :185-192
[6]   GROWTH IN-UTERO AND SERUM-CHOLESTEROL CONCENTRATIONS IN ADULT LIFE [J].
BARKER, DJP ;
MARTYN, CN ;
OSMOND, C ;
HALES, CN ;
FALL, CHD .
BRITISH MEDICAL JOURNAL, 1993, 307 (6918) :1524-1527
[7]   FETAL AND PLACENTAL SIZE AND RISK OF HYPERTENSION IN ADULT LIFE [J].
BARKER, DJP ;
BULL, AR ;
OSMOND, C ;
SIMMONDS, SJ .
BRITISH MEDICAL JOURNAL, 1990, 301 (6746) :259-262
[8]  
Blabev S. J. M., 1970, Proc. malac. Soc. Lond., V39, P231
[9]   Role of macrophage tissue infiltration in metabolic diseases [J].
Bouloumié, A ;
Curat, CA ;
Sengenès, C ;
Lolmède, K ;
Miranville, A ;
Busse, R .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (04) :347-354